Evidence map›Paper›PMID 30722780›Full record

ArticleBMC pediatrics2019

High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal.

Abdoul-Magib Cissé, Gabrièle Laborde-Balen, Khady Kébé-Fall, Aboubacry Dramé, Halimatou Diop, Karim Diop, FatouNiasse-Traoré, Mohamed Coulibaly, Ndeye-Ngone Have, Nicole Vidal and 6 more

Abstract read
In one paragraph

Article in BMC pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Abdoul-Magib CisséService de pédiatrie Établissement Public de Santé (EPS) de Mbour, UFR Sciences de la Santé, Thiès University, Thiès, Senegal.
Gabrièle Laborde-BalenExpertise France, Paris, France.
Khady Kébé-FallBacteriology-Virology Laboratory, A. Le Dantec CHU, Cheikh Anta Diop University, Dakar, Senegal.
Aboubacry DraméBacteriology-Virology Laboratory, A. Le Dantec CHU, Cheikh Anta Diop University, Dakar, Senegal.
Halimatou DiopBacteriology-Virology Laboratory, A. Le Dantec CHU, Cheikh Anta Diop University, Dakar, Senegal.
Karim DiopExpertise France, Paris, France.
FatouNiasse-TraoréConseil national de lutte contre le sida (CNLS), Dakar, Senegal.
Mohamed CoulibalyDivision de lutte contre le sidxa et les IST (DLSI), Ministry of Health and Social Action (MSAS), Dakar, Senegal.
Ndeye-Ngone HaveRéseau national des associations de personnes vivant avec le VIH au (RNP+), Dakar, Senegal.
Nicole VidalInstitut de Recherche pour le Développement (IRD), Montpellier, France.
Safiatou ThiamConseil national de lutte contre le sida (CNLS), Dakar, Senegal.
Abdoulaye S WadeDivision de lutte contre le sidxa et les IST (DLSI), Ministry of Health and Social Action (MSAS), Dakar, Senegal.
Martine PeetersInstitut de Recherche pour le Développement (IRD), Montpellier, France.
Bernard TaverneCentre régional de recherche et de formation à la prise en charge clinique de Fann (CRCF), Dakar, Senegal.
Philippe MsellatiInstitut de Recherche pour le Développement (IRD), Montpellier, France. philippe.msellati@ird.fr.ORCID 0000-0003-2568-1626
Coumba Touré-KaneBacteriology-Virology Laboratory, A. Le Dantec CHU, Cheikh Anta Diop University, Dakar, Senegal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Senegal in 2015, an estimated 4800 children were living with HIV, with 1200 receiving ARV treatment, of whom half had follow-up care in decentralized sites outside Dakar. However, until now no studies have determined the efficacy of pediatric treatment in decentralized settings, even though the emergence of viral resistance, particularly among children in Africa, is a well-known phenomenon. This study aimed to assess the virological status of HIV-infected children in all decentralized facilities to help improve access to quality care.

methodsA cross-sectional epidemiological and virological study was conducted in all of Senegal's regions, except Dakar, between March and June 2015 and sought to include all HIV-infected children and adolescents (0-19 years), treated or not with ARVs. Socio-demographic and clinical data and a blood sample on blotting paper were collected for children from treatment sites. Samples were routed on public transportation, assisted by a network of community health workers. A viral load (VL) assay was performed for each child, followed by genotyping when it exceeded 1000 copies/mL (3 log

resultsOf the 851 identified children, 666 (78%) were enrolled in the study. Half of the children were girls, and the average age was 8 years (6 months-19 years). Most of the children (96.7%) were infected with HIV-1, and 90% were treated with ART, primarily with AZT + 3TC + NVP/EFV therapeutic regimen. The median duration of time on ART was 21 months (1-129). VL was measured for 2% of children before this study. Almost two-thirds (64%) of the children are experiencing virological failure. Among them, there was resistance to at least one drug for 86.5% of cases. Also, 25% children presented resistance to one drug and 40% to two out of three. For nearly one-third of the children presenting resistance, none of the three drugs of the treatment was active. Factors associated with virological failure were male sex, follow-up by a generalist rather than a specialist, and treatment interruptions.

conclusionsWe observed a high level of virological failure and a high percentage of viral resistance among children receiving health care in decentralized facilities in Senegal.

Indexed as

Drug Resistance, ViralTreatment FailureAdolescentAnti-Retroviral AgentsChildChild, PreschoolCross-Sectional StudiesDelivery of Health CareFemaleHIV InfectionsHumansInfantMaleSenegalYoung AdultAnti-Retroviral AgentsAntiretroviralDecentralizationPediatric HIVSenegalViral resistance

Identifiers

PMID30722780
PMCPMC6362577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.